We are live on ! Find out more
SCR

SIMCERE PHARMACEUTICAL GROUP, ADS
SCR

Delisted

SCR was delisted on the 23rd of December, 2013.

Back to rankings

12 hedge funds and large institutions have $3.23M invested in SIMCERE PHARMACEUTICAL GROUP, ADS in 2013 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 1

40% less funds holding

Funds holding: 20 → 12 (-8)

62% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 13

71% less call options, than puts

Call options by funds: $45K | Put options by funds: $155K

84% less capital invested

Capital invested by funds: $20.1M → $3.23M (-$16.8M)

100% less funds holding in top 10

Funds holding in top 10: 1 → 0 (-1)

Holders
12
Holders Change
-8
Holders Change %
-40%
% of All Funds
0.35%
Holding in Top 10
–
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
–
New
5
Increased
2
Reduced
1
Closed
13
Calls
$45K
Puts
$155K
Net Calls
-$110K
Net Calls Change
+$279K

Top Buyers

1
SG Americas Securities
SG Americas Securities
New York
+$1.28M
2
LOM
Loeb Offshore Management
New York
+$480K
3
Barclays
Barclays
United Kingdom
+$41.6K
4
Morgan Stanley
Morgan Stanley
New York
+$10.9K
5
U
UBS
Switzerland
+$9.49K

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$5.67M
2
PRCM
Pine River Capital Management
Minnesota
-$4.07M
3
SGA
Siguler Guff Advisers
New York
-$3.24M
4
PCM
Pentwater Capital Management
Florida
-$2.58M
5
WAM
Wolverine Asset Management
Illinois
-$959K
Name Holding Trade Value Shares
Change 		Change in
Stake
SG Americas Securities
1
SG Americas Securities
New York
$1.29M +$1.28M +134,813 New
COPPSERS
2
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$1.05M -$34.2K -3,600 -3%
LOM
3
Loeb Offshore Management
New York
$488K +$480K +50,575 New
Baillie Gifford & Co
4
Baillie Gifford & Co
United Kingdom
$236K – – –
Barclays
5
Barclays
United Kingdom
$97K +$41.6K +4,379 +69%
U
6
UBS
Switzerland
$22K +$9.49K +999 +80%
Group One Trading
7
Group One Trading
Illinois
$17K – – –
Bank of America
8
Bank of America
North Carolina
$14K – – –
Morgan Stanley
9
Morgan Stanley
New York
$11K +$10.9K +1,143 New
US Bancorp
10
US Bancorp
Minnesota
$2K +$1.86K +196 New
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
– -$5.67M -599,300 Closed
PRCM
12
Pine River Capital Management
Minnesota
– -$4.07M -430,444 Closed
SGA
13
Siguler Guff Advisers
New York
– -$3.24M -342,936 Closed
PCM
14
Pentwater Capital Management
Florida
– -$2.58M -272,209 Closed
WAM
15
Wolverine Asset Management
Illinois
– -$959K -101,409 Closed
EC
16
EJF Capital
Virginia
– -$463K -48,994 Closed
HK
17
Horizon Kinetics
New York
– -$454K -48,000 Closed
Renaissance Technologies
18
Renaissance Technologies
New York
– -$375K -39,600 Closed
Acadian Asset Management
19
Acadian Asset Management
Massachusetts
– -$283K -30,009 Closed
TD Asset Management
20
TD Asset Management
Ontario, Canada
– -$214K -22,600 Closed
California Public Employees Retirement System
21
California Public Employees Retirement System
California
– -$185K -19,500 Closed
Deutsche Bank
22
Deutsche Bank
Germany
– -$150K -15,900 Closed
BFA
23
BlackRock Fund Advisors
California
– -$2K -171 Closed
Citigroup
24
Citigroup
New York
– +$456 +48 New

SCR Hedge Fund Activity: Q4 2013 in Review

12 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) for Q4 2013, worth a combined $3.23M — down 84% from $20.1M a quarter earlier.

Sellers outnumbered buyers: 13 funds closed out of SCR and 5 opened new positions — a net loss of 8 holders — while 1 trimmed existing stakes and 2 added.

The largest buyer was SG Americas Securities, opening a new position worth an estimated $1.28M. The largest seller was T. Rowe Price Associates, exiting entirely with an estimated $5.67M sold.

  • 12 institutional investors held SIMCERE PHARMACEUTICAL GROUP, ADS (SCR) as of Q4 2013, down from 20 in Q3 2013.
  • Funds reported $3.23M of SIMCERE PHARMACEUTICAL GROUP, ADS stock for Q4 2013, down 84% quarter-over-quarter.
  • 5 funds opened new SIMCERE PHARMACEUTICAL GROUP, ADS positions in Q4 2013 and 13 closed out, a net change of -8 holders.
  • The largest SIMCERE PHARMACEUTICAL GROUP, ADS buyer in Q4 2013 was SG Americas Securities, an estimated $1.28M added.
  • The largest SIMCERE PHARMACEUTICAL GROUP, ADS seller in Q4 2013 was T. Rowe Price Associates, an estimated $5.67M sold.

Based on aggregated 13F filings for Q4 2013.